Question 1

How many shares of DNLI does Ensign Peak Advisors, Inc own?

Accepted Answer

As of 2026-Q2, Ensign Peak Advisors, Inc holds 582,669 shares of DNLI (DENALI THERAPEUTICS INC).

Question 2

What is Ensign Peak Advisors, Inc's DNLI position worth?

Accepted Answer

As of 2026-Q2, Ensign Peak Advisors, Inc's DNLI position is worth $15M.

Question 3

Is Ensign Peak Advisors, Inc buying or selling DNLI?

Accepted Answer

In 2026-Q2, Ensign Peak Advisors, Inc increased their DNLI position (+13.0% change in shares).

Question 4

When did Ensign Peak Advisors, Inc first buy DNLI?

Accepted Answer

Based on available 13F filings, Ensign Peak Advisors, Inc first reported a position in DNLI in 2024-Q3. They have held the position across 27 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	582,669	+13.0%	$15M	0.0%	$25.72	32
2026-Q1	Unchanged	515,721	0.0%	$9.9M	0.0%	$20.02	0
2025-Q4	Decreased	515,721	-3.4%	$8.5M	0.0%	$16.41	0
2025-Q3	Increased	534,071	+12.8%	$7.8M	0.0%	$14.52	31
2025-Q2	Decreased	473,695	-19.4%	$6.6M	0.0%	$14.10	0
2025-Q1	Increased	587,785	+69.7%	$8M	0.0%	$14.78	41
2024-Q4	Unchanged	346,304	0.0%	$7.1M	0.0%	$20.24	0
2024-Q3	Unchanged	346,304	0.0%	$10.1M	0.0%	$29.43	0